Clinical Research
Total Trials
12
As Lead Sponsor
1
As Collaborator
11
Total Enrollment
10,878
NCT02389413
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
Phase: Phase 2
Role: Collaborator
Start: Mar 31, 2015
Completion: Apr 30, 2017
NCT03227146
Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Start: Oct 25, 2017
Completion: Aug 31, 2025
NCT03229564
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children
Completion: Jun 30, 2028
NCT03394612
Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children
Start: Feb 14, 2018
Completion: Dec 31, 2026
NCT04165239
The KHENERGYZE Study
Start: Oct 30, 2019
Completion: May 24, 2022
NCT04846036
The KHENERGYC Study
Start: Feb 1, 2021
Completion: Dec 1, 2025
NCT04788745
Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)
Start: Jun 29, 2021
Completion: May 24, 2023
NCT04604548
The KHENEREXT Study
Start: Aug 9, 2021
Completion: Jun 1, 2023
NCT05178810
Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis
Phase: Phase 3
Start: Oct 18, 2021
Completion: Oct 26, 2023
NCT05651724
Global Research Initiative for Patients Screening on MASH
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2023
Completion: Mar 31, 2031
NCT06182085
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Start: Dec 1, 2023
Completion: Apr 30, 2026
NCT05731375
Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage
Start: Apr 30, 2024
Completion: Dec 31, 2025
Loading map...